---

Bhringraj (Eclipta alba / Eclipta prostrata) - Components and Local Scalp Effects

Botanical Identity

• Family: Asteraceae
• Common name: Bhringraj, False Daisy, Ink Plant
• Synonyms: Eclipta alba (Hassk.), Eclipta prostrata (L.)
• Parts used: Leaves, whole plant, extracted oil

---

Active Chemical Components

1. Coumestans (Primary active class)

• Wedelolactone - the signature compound; most studied
• Demethylwedelolactone - co-major constituent
• These are potent anti-inflammatory agents that also inhibit NF-kB signaling

2. Alkaloids

• Ecliptine - a key nitrogenous alkaloid associated with hair pigmentation and follicle stimulation
• Nicotine (trace amounts)

3. Flavonoids

• Luteolin
• Apigenin
• These exhibit antioxidant and anti-inflammatory effects locally

4. Phenolic Acids

• 4-Hydroxybenzoic acid
• Protocatechuic acid
• Chlorogenic acid - strong antioxidant; absorbs UVA/UVB radiation, protects scalp keratinocytes

5. Triterpenoid and Steroid Saponins

• Eclalbasaponins I-VI
• Ecliptasaponins A-D
• Promote cell membrane integrity and have mild antimicrobial action on the scalp

6. Substituted Thiophenes

• Unique to this genus; contribute to its antimicrobial profile

7. Other Phytoconstituents

• Steroids (sitosterol, stigmasterol)
• Polypeptides and tannins
• Essential fatty acids (in oil preparations)

---

Local Effects on the Scalp

1. Hair Follicle Stimulation and Anagen Promotion

• Significantly increased the number of follicles in the anagen (growth) phase: 69 ± 4 in treated rats vs. 47 ± 13 in controls
• In pigmented C57/BL6 mice, a dose of 3.2 mg/15 cm² induced a telogen-to-anagen transition in 87.5% of animals (vs. 50% at half the dose), confirming a dose-dependent response
• The Begum et al. 2015 study (PMID 25484129) showed that Eclipta alba promotes hair matrix keratinocyte proliferation and downregulates TGF-β1 (a key inhibitor of hair growth)

2. 5-Alpha-Reductase Inhibition

• Wedelolactone and flavonoids inhibit 5α-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT)
• Reducing scalp DHT levels directly slows androgenic hair loss (androgenetic alopecia)

3. Improved Scalp Microcirculation

• Vasodilatory properties of flavonoids (luteolin, apigenin) enhance blood flow to the dermal papilla
• Improved nutrient delivery to hair roots, comparable in some rat studies to topical minoxidil - with E. alba showing equal or superior follicular response

4. Anti-inflammatory Action on the Scalp

• Wedelolactone inhibits NF-kB and reduces pro-inflammatory cytokines (IL-1β, TNF-α)
• Reduces scalp inflammation associated with seborrheic dermatitis, folliculitis, and alopecia areata
• A polyherbal formulation combining E. alba, Hibiscus rosa-sinensis, and Nardostachys jatamansi showed significantly reduced hair growth initiation time in Wistar rats

5. Antioxidant and UV Protection

• Water extracts scavenge DPPH and superoxide radicals (IC₅₀ = 0.23 mg/mL for DPPH)
• Chelates ferrous ions, reducing oxidative damage to scalp tissue
• Chlorogenic acid absorbs UVA and UVB, protecting HaCaT keratinocytes and fibroblasts from UV-induced cytotoxicity - reduces sun-related scalp damage and premature hair aging

6. Antimicrobial / Anti-dandruff Effects

• Thiophene derivatives and saponins inhibit bacterial and fungal growth on the scalp
• Effective against organisms responsible for seborrheic dermatitis and scalp infections

7. Scalp Melanocyte / Hair Pigmentation Support

• Ecliptine is traditionally associated with preventing premature graying
• Animal studies suggest anagen-phase coupling with melanocyte activation, supporting hair darkening effects

8. Collagen Synthesis Enhancement

• Stimulates collagen in the skin and hair roots, strengthening the anchoring of hair in the follicle
• Reduces hair breakage and improves tensile strength of the hair shaft

---

Summary Table

---

• Roy RK et al. 2008 - Arch Dermatol Res - Hair growth promoting activity in albino rats
• Begum S et al. 2015 - Int J Mol Med - Keratinocyte proliferation and TGF-β1 downregulation
• PMC4897414 - Ethnopharmacological Significance of Eclipta alba
• PMC8615741 - Eclipta prostrata phytoconstituents and biological activities

---

Bhringraj vs Minoxidil vs Finasteride in Alopecia Management

---

1. Mechanism of Action

---

2. Clinical Efficacy Evidence

Bhringraj

• Evidence is limited to animal models (albino rats, C57/BL6 mice) - no published large-scale RCTs in humans
• Roy et al. 2008 (PMID 18478241): Topical petroleum ether extract (2% and 5%) showed better hair growth initiation and completion than minoxidil 2% (positive control) in rats - follicles in anagen phase: 69 ± 4 (treated) vs 47 ± 13 (control)
• Begum et al. 2015 (PMID 25484129): Promoted hair matrix keratinocyte proliferation and downregulated TGF-β1 in nude mice
• Dose-dependent telogen-to-anagen transition: 87.5% of mice at 3.2 mg/15 cm² vs 50% at 1.6 mg/15 cm²
• ⚠ No human RCT data. All comparative claims vs minoxidil are animal-model only.

Minoxidil

• FDA-approved for androgenetic alopecia (AGA) in men (5%) and women (2%, 5%)
• Adil & Godwin 2017 meta-analysis (PMID 28396101): All doses superior to placebo (p < 0.00001) across multiple RCTs
• 5% minoxidil superior to 2% for hair density and growth
• Hair density increase: ~7-18% above baseline at 48 weeks
• Effects are reversible - hair loss resumes within 3-6 months of stopping
• Olsen 2002: Topical minoxidil 5% increased terminal hair density by +4.2% (vs finasteride +7.1%, combination +12.4%)

Finasteride

• FDA-approved at 1 mg/day oral for male AGA
• Kaufman 1998: After 2 years, 83% of finasteride-treated men maintained or increased hair count vs 28% with placebo
• Gupta et al. 2024 network meta-analysis (PMID 38725143): Oral 5α-reductase inhibitors ranked more effective than oral minoxidil and all other monotherapies for male AGA; dutasteride 0.5 mg/day ranked highest (SUCRA = 87-98%)
• Head-to-head vs minoxidil 5%: Clinical cure rate 80% (finasteride) vs 52% (minoxidil 5%) in one RCT (PMID 15316165)
• Not recommended in women of childbearing potential (teratogenic - Type X)

---

3. Efficacy Ranking (Evidence-Based)

Finasteride + Minoxidil (combination) > Finasteride > Minoxidil 5% > Minoxidil 2% >>> Bhringraj (insufficient human data)

---

4. Safety Profile Comparison

---

5. Use in Women

---

6. Practical Comparison

---

7. Bottom Line

• Finasteride is the most effective monotherapy for male androgenetic alopecia when the androgenic driver (DHT) is the primary cause. Its superiority in head-to-head studies (80% vs 52% clinical cure) is clear, but sexual side effects and contraindication in women are real limitations.
• Minoxidil is the first-line choice for both men and women, FDA-approved, and works regardless of androgen status. It is especially useful when finasteride is contraindicated.
• Combination (minoxidil + finasteride) is now supported by the 2023 AAD guidelines as the most effective non-surgical approach for male AGA.
• Bhringraj has biologically plausible mechanisms and promising preclinical data, but lacks human RCT evidence. It cannot currently be recommended as a replacement for either drug. Its value lies as a safe, low-cost adjunct - particularly for mild cases, scalp health maintenance, anti-inflammatory support, and in populations where pharmaceutical options are declined or contraindicated.

---

• Adil & Godwin 2017 - JAAD Meta-analysis (PMID 28396101)
• Roy et al. 2008 - Eclipta alba vs Minoxidil in rats (PMID 18478241)
• Gupta et al. 2024 - Network meta-analysis monotherapies (PMID 38725143)
• Finasteride vs Minoxidil head-to-head RCT (PMID 15316165)

---

Bhringraj - Ayurvedic Qualities and Scalp Effects

---

1. Sanskrit Names and Significance

---

2. Ayurvedic Pharmacological Properties (Dravyaguna)

Rasa (Taste)

Note: Some Ayurvedic schools (e.g., Banyan Botanicals tradition) also include a Madhura (sweet) component, giving it a more tridoshic character. The easyayurveda.com classical interpretation holds Katu + Tikta as primary.

Guna (Physical Qualities)

Virya (Potency/Energy)

Vipaka (Post-digestive transformation)

Prabhava (Special action beyond expected)

• Rasayana - Rejuvenating effect beyond what its rasa/guna/virya would predict - regenerates hair tissue at the cellular level

---

3. Dosha Action on the Scalp

Bhringraj is primarily a Vata-Kapha shamaka (pacifier)

In classical texts like Bhavaprakash Nighantu, Bhringraj is described as Pitta-Vata shamaka - the Tikta rasa cools Pitta locally while Ushna virya handles Vata.

---

4. Classical Scalp Karma (Actions)

---

5. Ayurvedic Hair Diseases and Bhringraj's Role

A. Khalitya (Alopecia / Hair Loss)

• Dosha involved: Primarily Pitta with Vata; Kapha and Rakta obstruct romakoopa (follicle)
• Pathogenesis: Tejas (fire energy) + Vata scorches hair roots → follicle death
• Bhringraj action: Ushna virya clears Vata obstruction; Tikta reduces Pitta excess; opens srota to restore follicular blood flow
• Classical formulation: Bhringaraj Taila as Shiropichu (scalp packing therapy)

B. Palitya (Premature Greying)

• Dosha: Pitta-dominant; also associated with Vata body heat scorching melanocytes
• Pathogenesis: Partial scorching of hair roots (vs. full scorching = Khalitya)
• Bhringraj action: Kesharanjana karma - ecliptine and natural darkening agents support melanocyte function; acts as Nasya (nasal instillation) and Abhyanga (head massage oil)
• Classical text reference (Charaka, Trimarmiya Chikitsa): Bhringaraj taila listed among medicated oils for Palitya treatment

C. Darunaka (Dandruff / Seborrheic Dermatitis)

• Dosha: Vata-Kapha; dryness + congestion of scalp channels
• Bhringraj action: Krimighna + Shophahara karma - antimicrobial and anti-inflammatory, reduces flaking and itching; Ruksha guna reduces Kapha-type oiliness

D. Indralupta (Alopecia Areata)

• Dosha: Tridoshic with Rakta involvement
• Bhringraj action: Rasayana + Vranaropana - used as part of Lepa (paste application) to rejuvenate dormant follicles

---

6. Asthi Dhatu Connection - Why Bhringraj Works Systemically

• Mala (metabolic waste product) of Asthi Dhatu (bone tissue) - per Charaka and Sushruta
• Or Upadhatu of Majja Dhatu - per Sharangadhara

---

7. Classical Ayurvedic Scalp Formulations Featuring Bhringraj

• Shiroabhyanga - scalp oil massage (primary method)
• Shiropichu - cotton pad soaked in oil placed on scalp
• Nasya - nasal instillation for Palitya and systemic hair support
• Lepa - fresh paste of leaves applied topically for infected or inflamed scalp

---

8. Correlation Between Ayurvedic Properties and Modern Pharmacology

---

• Bhavaprakash Nighantu (classical Ayurvedic text) - primary reference for Bhringraj properties
• Charaka Samhita, Trimarmiya Chikitsa - Palitya and Khalitya management
• Saini et al. 2024 - IJRAP, Jeemuta Bhringadi Taila review
• Concept of Kesha and Its Diseases - Amrit Kalash Journal, 2026
• EasyAyurveda - Bhringraj medicinal properties